We observed that PPPIR15A was reduced in lung fibroblasts in IPF patients and that TGFβ-induced fibroblast activation further decreased PPPIR15A. PPPIR15A deficiency or its pharmacological inhibition exacerbated experimental lung fibrosis. This evidence concerns the gene TGFB1 and pulmonary fibrosis.